References
- Buhl, C., Olsen, N. L., Nørgaard, L. S., Thomsen, L. A., & Jacobsen, R. (2023). Community pharmacy staff’s knowledge, educational needs, and barriers related to counseling cancer patients and cancer survivors in Denmark. International Journal of Environmental Research and Public Health, 20(3), 2287. https://doi.org/10.3390/ijerph20032287
- Cavallier, G., Laudet, M., Vayssettes, P.-M., Balayssac, D., & Chennell, P. (2022). [Hospital– community pharmacy coordination for the dispensing of oral antineoplastic drugs: An observational study in the French county of the Aveyron]. Bulletin Du Cancer, 109(6), 692–706. https://doi.org/10.1016/j.bulcan.2022.02.007
- Colombo, L. R. P., Aguiar, P. M., Lima, T. M., & Storpirtis, S. (2017). The effects of pharmacist interventions on adult outpatients with cancer: A systematic review. Journal of Clinical Pharmacy and Therapeutics, 42(4), 414–424. https://doi.org/10.1111/jcpt.12562
- Craigs, C. L., Bennett, M. I., Hurlow, A., West, R. M., & Ziegler, L. E. (2018). Older age is associated with less cancer treatment: A longitudinal study of English cancer patients. Age and Ageing, 47(6), 833–840. https://doi.org/10.1093/ageing/afy094
- Foundation for Promotion of Cancer Research. (2023, April 26). Cancer statistics in Japan 2023. https://ganjoho.jp/public/qa_links/report/statistics/2023_en.html.
- Gatwood, J., Gatwood, K., Gabre, E., & Alexander, M. (2017). Impact of clinical pharmacists in outpatient oncology practices: A review. American Journal of Health-System Pharmacy, 74(19), 1549–1557. https://doi.org/10.2146/ajhp160475
- Haase, K. R., Sattar, S., Pilleron, S., Lambrechts, Y., Hannan, M., Navarrete, E., Kantilal, K., Newton, L., Kantilal, K., Jin, R., Wal-Huisman, H. van der, Strohschein, F. J., Pergolotti, M., Read, K. B., Kenis, C., & Puts, M. (2023). A scoping review of ageism towards older adults in cancer care. Journal of Geriatric Oncology, 14(1), 101385. https://doi.org/10.1016/j.jgo.2022.09.014
- Hébert, G., Minvielle, E., Palma, M. D., & Lemare, F. (2018). Quelles Sont Les Attentes de Coordination et d’accompagnement Des Patients Français Atteints de Cancer Vis-à-Vis de Leur Pharmacien de Ville ? Bulletin Du Cancer, 105(3), 245–255. doi: 10.1016/j.bulcan.2017.11.017
- Herledan, C., Cerfon, M.-A., Baudouin, A., Larbre, V., Lattard, C., Poletto, N., Ranchon, F., & Rioufol, C. (2023a, May 1). Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic review. Journal of Geriatric Oncology, 14(4), 101450. https://doi.org/10.1016/j.jgo.2023.101450
- Herledan, C., Toulemonde, A., Clairet, A.-L., Boulin, M., Falandry, C., Decker, L. D., Rioufol, C., Bayle, A., & Bertrand, N. (2023b, October 1). Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO. Critical Reviews in Oncology/Hematology, 190, 104117. https://doi.org/10.1016/j.critrevonc.2023.104117
- Jordan, K., Aapro, M., Kaasa, S., Ripamonti, C. I., Scotté, F., Strasser, F., Young, A., Bruera, E., Herrstedt, J., Keefe, D., Laird, B., Walsh, D., Douillard, J. Y., & Cervantes, A. (2018). European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Annals of Oncology, 29(1), 36–43. https://doi.org/10.1093/annonc/mdx757
- Kimura, M., Go, M., Iwai, M., Usami, E., Teramachi, H., & Yoshimura, T. (2017). Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer. Molecular and Clinical Oncology, 7(3), 486–492. https://doi.org/10.3892/mco.2017.1337
- Mensah, K. B., Bangalee, V., & Oosthuizen, F. (2019). Assessing knowledge of community pharmacists on cancer: A pilot study in Ghana. Frontiers in Public Health, 7, 13. https://doi.org/10.3389/fpubh.2019.00013
- Ministry of Health, Labour and Welfare. (2009, May). Serious adverse reaction disease manual – peripheral neuropathy. https://www.pmda.go.jp/files/000143545.pdf.
- Ministry of Health, Labour and Welfare. (2015, October 23). Pharmacy vision for patients. https://www.mhlw.go.jp/file/04-Houdouhappyou-11121000-Iyakushokuhinkyoku-Soumuka/vision_1.pdf.
- Ministry of Health, Labour and Welfare. (2018, March). The basic plan to promote cancer control programs (3rd period). https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000196975.pdf.
- Ministry of Health, Labour and Welfare. (2021b, October 22). Central social insurance medical council 22 October, 2021. https://www.mhlw.go.jp/content/12404000/000846192.pdf.
- Ministry of Health, Labour and Welfare. (2022a, February). Manual for immune-related adverse events caused by immune checkpoint inhibitor. https://www.pmda.go.jp/files/000245271.pdf.
- Ministry of Health, Labour and Welfare. (2022b, August). Explanation of the 7th NDB Open Data Japan. https://www.mhlw.go.jp/content/12400000/001126104.pdf.
- Ministry of Health. Labour and Welfare. (n.d.-a). Cancer registration. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/gan/gan_toroku.html.
- Ministry of Health, Labour and Welfare. (n.d.-b). International statistical classification of diseases and related health problems. https://www.mhlw.go.jp/toukei/sippei/.
- Ministry of Health, Labour and Welfare. (n.d.-c). Medical information coordination network support navigator (archive). https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryou/johoka/renkei-support.html.
- Ministry of Health, Labour and Welfare. (n.d.-d). NDB Open Data Japan. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177182.html.
- Ministry of Health, Labour and Welfare. (n.d.-e). Revision of medical fee for FY 2020. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000188411_00027.html.
- Ministry of Health. Labour and Welfare. (n.d.-f). The 7th NDB Open Data Japan. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177221_00011.html.
- Ministry of Health, Labour and Welfare. (Revised 2019, September). Serious adverse reaction disease manual – hand-foot syndrome. https://www.pmda.go.jp/files/000240132.pdf.
- Ministry of Health, Labour and Welfare. (Revised 2021a, April). Serious adverse reaction disease manual – severe diarrhea. https://www.pmda.go.jp/files/000240118.pdf.
- Ministry of Health, Labour and Welfare. (Revised 2023, April). Serious adverse reaction disease manual – stomatitis caused by anticancer drug. https://www.pmda.go.jp/files/000252186.pdf.
- Ministry of Internal Affairs and Communications. (n.d.). Division 87 – Drugs and related commodities. https://www.soumu.go.jp/main_content/000294493.pdf.
- Mukai, R., Shimada, K., Suzuki, T., Nakao, S., Tanaka, M., Matsumoto, K., Yoshida, Y., Goto, F., Inoue, M., Satake, R., Nishibata, Y., Sugihara, H., & Nakamura, M. (2020). Trends associated with hemorrhoids in Japan: Data mining of medical information datasets and the national database of health insurance claims and specific health checkups of Japan (NDB) Open Data Japan. Biological and Pharmaceutical Bulletin, 43(12), 1831–1838. https://doi.org/10.1248/bpb.b20-00157
- Multinational Association of Supportive Care in Cancer. (n.d.). MASCC Guidelines. https://mascc.org/resources/mascc-guidelines/.
- National Comprehensive Cancer Network. (n.d.-a). NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Older Adult Oncology Version 1. 2023. https://www.nccn.org/guidelines/guidelines-detail?category=4&id=1452.
- National Comprehensive Cancer Network. (n.d.-b). NCCN clinical practice guidelines in oncology (NCCN Guidelines®) antiemesis version 2. 2023. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1415.
- National Comprehensive Cancer Network. (n.d.-c). Supportive Care. https://www.nccn.org/guidelines/category_3.
- Okuyama, A., & Higashi, T. (2018). Patterns of cancer treatment in different age groups in Japan: An analysis of hospital-based cancer registry data, 2012–2015. Japanese Journal of Clinical Oncology, 48(5), 417–425. https://doi.org/10.1093/jjco/hyy032
- Rubira, L., Leenhardt, F., Perrier, C., & Pinguet, F. (2021). Sécurisation du parcours de soins du patient sous thérapie orale en oncologie: Expérimentation autour d’un lien pharmaceutique hôpital–ville. Annales Pharmaceutiques Françaises, 79(5), 558–565. https://doi.org/10.1016/j.pharma.2021.01.009
- Sehgal, R., Alsharedi, M., Larck, C., Edwards, P., & Gress, T. (2014). Pancreatic cancer survival in elderly patients treated with chemotherapy. Pancreas, 43(2), 306–310. https://doi.org/10.1097/MPA.0000000000000091
- Statistics Bureau of Japan. (n.d.). Vital Statistics Vital Statistics of Japan Final Data Population Yearly 2020 | File | Browse Statistics. https://www.e-stat.go.jp/en/stat-search/files?page=1&layout=datalist&toukei=00450011&tstat=000001028897&cycle=7&year=20200&month=0&tclass1=000001053058&tclass2=000001053061&tclass3=000001053072&result_back=1&tclass4val=0.
- Suzuki, T., Iwata, M., Maezawa, M., Inoue, M., Satake, R., Wakabayashi, W., Oura, K., Tanaka, H., Hirofuji, S., Miyasaka, K., Goto, F., Nakao, S., Masuta, M., Iguchi, K., & Nakamura, M. (2023). Promoting generic drug usage in Japan: Correlation between generic drug usage and monthly personal income. Journal of Pharmaceutical Policy and Practice, 16(1), 27. https://doi.org/10.1186/s40545-023-00532-5
- Tanaka, H., Onoda, T., & Ishii, T. (2022). Understanding the actual use of anti-HIV drugs in Japan from 2016 to 2019: Demonstrating epidemiological relevance of NDB Open Data Japan for understanding Japanese medical care. International Journal of Environmental Research and Public Health, 19(19), 12130. https://doi.org/10.3390/ijerph191912130
- Tanaka, K., Tachi, T., Hori, A., Osawa, T., Nagaya, K., Makino, T., Inoue, S., Yasuda, M., Mizui, T., Nakada, T., Goto, C., & Teramachi, H. (2019). Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients. Die Pharmazie, 74(7), 439–442. https://doi.org/10.1691/ph.2019.9327
- Tanito, M. (2022). Nation-wide analysis of glaucoma medication prescription in fiscal year of 2019 in Japan. Journal of Personalized Medicine, 12(6), 956. https://doi.org/10.3390/jpm12060956
- Urakawa, R., Hashimoto, S., Hirohata, H., Sakai, K., Matsuura, K., Ito, Y., Tarutani, M., Kubota, K., Ueda, M., & Uejima, E. (2021). Skin disorder management in oral anticancer drugs by collaboration of hospital pharmacists and community pharmacists. Supportive Care in Cancer, 29(7), 3577–3583. https://doi.org/10.1007/s00520-020-05875-2
- World Health Organization. (n.d.). Cancer. Retrieved October 27, 2023, from https://www.who.int/news-room/fact-sheets/detail/cancer.
- Yoshimi, C., Yamada, M., Fujii, H., Nishigaki, M., Iihara, H., Kitaichi, K., Takahashi, M., Kurahashi, S., Takahashi, T., Yoshida, K., & Itoh, Y. (2013). [Evaluation of the efforts of pharmaceutical care services before medical examination at an outpatient cancer chemotherapy clinic]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 40(3), 349–354.